With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.21043-40-3,1-Cyclopentylpiperazine,as a common compound, the synthetic route is as follows.,21043-40-3
Example 1 (General procedure A); 6-Chloro-2-(4-cyclopentylpiperazin-1-yl)benzothiazole, hydrochloride; A mixture of 2,6-dichlorobenzothiazole (0.39 g, 1.9 mmol), 1-cyclopentylpiperazine (0.22 g, 1.4 mmol) and dimethylsulfoxide (2.0 ml.) was stirred at 130 0C for 23 h. The reaction mixture was allowed to cool and water (50 ml.) and potassium carbonate (1 g) was added. The resulting mixture was extracted with a mixture of ethyl acetate and dichloromethane and filtered. The filtrate was separated and the organic extract was washed with brine (2 x) and dried (MgSO4). The volatiles were evaporated to give a solid residue which was dissolved into a mixture of ethanol (30 ml.) and 1 N hydrochloric acid (2.5 ml_). Toluene was added and the mixture was concentrated. Ethanol and toluene was added and the mixture was concentrated again. This afforded a solid which was treated with ethanol (50 ml.) and heated to reflux temperature. The resulting mixture was left overnight for crystallization. This afforded after filtration and drying 0.35 g (69 %) of 6-chloro-2-(4-cyclopentylpiperazin-1-yl)benzo- thiazole, hydrochloride.
The synthetic route of 21043-40-3 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; NOVO NORDISK A/S; WO2007/110364; (2007); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics